Shuttle Pharmaceuticals Holdings (SHPH) Total Current Liabilities (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Total Current Liabilities of $8.3 million for Q1 2026, up 366.04% year-over-year from $1.8 million in Q1 2025, and up 4.25% quarter-over-quarter from $8.0 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Total Current Liabilities (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 366.04% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 366.04% YoY), while the FY2025 annual figure was $8.0 million, up 419.43% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $8.3 million, up from $8.0 million in the prior quarter.
- The five-year high for Total Current Liabilities was $8.3 million in Q1 2026, with the low at $493682.0 in Q2 2023.
- The 5-year median for Total Current Liabilities is $1.5 million (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 56.0% in 2022, then jumped 419.43% in 2025.
- Shuttle Pharmaceuticals Holdings' Total Current Liabilities stood at $975676.0 in 2022, then gained by 6.82% to $1.0 million in 2023, then soared by 47.16% to $1.5 million in 2024, then surged by 419.43% to $8.0 million in 2025, then advanced by 4.25% to $8.3 million in 2026.
- Business Quant data shows SHPH's Total Current Liabilities at $8.3 million in Q1 2026, $8.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.79 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 8.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.31 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 810,437.00 |
| Jun 30, 2023 | 493,682.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 975,676.00 |
| Sep 30, 2022 | 970,470.00 |
| Dec 31, 2021 | 2.22 Mn |